Regulation of CD95 (APO-1/Fas) receptor and ligand expression by lipopolysaccharide and dexamethasone in parenchymal and nonparenchymal rat liver cells

Hepatology

Volumn 27, Issue 1, 1998, Pages 200-208

  Muschen, M ^a   Warskulat, U ^a   Douillard, P ^a   Gilbert, E ^a   Hussinger, D ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; FAS ANTIGEN; LIPOPOLYSACCHARIDE;

ANIMAL CELL; APOPTOSIS; ARTICLE; IMMUNOREGULATION; KUPFFER CELL; LIGAND BINDING; LIVER CELL; LIVER DEVELOPMENT; LIVER REGENERATION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0031972578     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510270131     Document Type: Article

References (39)

1. 1 Payne CM, Bernstein C, Bernstein H. Apoptosis overview emphasizing the role of oxisative stress, DNA damage and signal transduction pathways. Leuk Lymphoma 1995 ; 19: 43–93. MEDLINE
2. 2 Crispe IN. Fatal interactions: Fas‐induced apoptosis of mature T cells. Immunity 1994 ; 1: 347–349. MEDLINE
3. 3 Lynch DH, Ramsdell F, Alderson MR. Fas and FasL in the homeostatic regulation of immune responses. Immunol Today 1995 ; 16: 569–574. MEDLINE
4. 4 Cory S. Fascinating death factor. Nature 1994 ; 367: 317–318. MEDLINE
5. 5 Steller H. Mechanisms and genes of cellular suicide. Science 1995 ; 267: 1445–1448. MEDLINE
6. 6 Evan GI, Brown L, Whyte M, Harrongton E. Apoptosis and the cell cycle. Curr Opin Cell Biol 1995 ; 7: 825–834. MEDLINE
7. 7 Que FG, Gores GJ. Cell death by apoptosis: basic concepts and disease relevance for the gastroenterologist. Gastroenterology 1996 ; 110: 1238–1243. MEDLINE
8. 8 Bursch W, Oberhammer F, Schulte‐Hermann R. Cell death by apoptosis and its protective role against disease. Trends Pharmacol Sci 1992 ; 13: 245–251. MEDLINE
9. 9 Trauth BC, Klas C, Peters AMJ, Matzku S, Möller P, Falk W, Debatin KM, Krammer PH. Monoclonal antibody‐mediated tumor regression by induction of apoptosis. Science 1989 ; 245: 301–305. MEDLINE
10. 10 Yonehar AS, IshiI A, Yonehar AM. A cell‐killing monoclonal antibody (anti‐Fas) to cell surface antigen co‐downregulated with the receptor of tumor necrosis factor. J Exp Med 1989 ; 169: 1747–1756. MEDLINE
11. 11 Itoh N, Yonehara S, Ishii A, Yonehara M, Mizuchima SI, Sameshima M, Hasa A, Seto Y, Nagata S. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991 ; 66: 2333–2343.
12. 12 Gruss HJ. Molecular, structural, and biological characteristics of the tumor necrosis factor ligand superfamily. Int J Clin Lab Res 1996 ; 26: 143–159. MEDLINE
13. 13 Suda T, Nagata S. Purification and characterization of the Fas‐ligand that induces apoptosis. J Exp Med 1994 ; 179: 873–879. MEDLINE
14. 14 Krammer PH, Behrmann I, Daniel P, Dhein J, Debatin KM. Regulation of apoptosis in the immune system. Curr Opin Immunol 1994 ; 6: 279–289. MEDLINE
15. 15 Benedetti AA, Jezaquel M, Orlandi F. Preferential distribution of apoptotic bodies in acinar zone 3 of normal human and rat liver. J Hepatol 1988 ; 7: 319–324. MEDLINE
16. 16 Adachi M, Suematsu S, Kondo T, Ogasawara J, Tanaka T, Yoshida N, Nagata S. Targeted mutation in the Fas gene causes hyperplasia in peripheral lymphoid organs and liver. Nat Genet 1995 ; 11: 294–299. MEDLINE
17. 17 Galle PR, Hofmann WJ, Walczak H, Schaller H, Otto G, Stremmel W, Krammer PH, Runkel L. Involvement of the CD95 (APO‐1/Fas) receptor and ligand in liver damage. J Exp Med 1995 ; 182: 1223–1230. MEDLINE
18. 18 Mochizuki K, Hayashi N, Hiramatsu N, Katayama K, Kawanishi Y, Kasahara A, Fusamoto H, Kamada T. Fas antigen expression in liver tissues of patients with chronic hepatitis B. J Hepatol 1996 ; 24: 1–7. MEDLINE
19. 19 Ohishi M, Sakisaka S, Koji T, Nakana PK, Tanikawa K. The localization of HCV and the expression of Fas antigen in the liver of HCV‐related chronic liver disease. Acta Histochem Cytochem 1995 ; 28: 341–348.
20. 20 Ogasawara J, Watanabe‐Fukunaga R, Adachi M, Matsuzawa A, Kasugai T, Kitamura Y, Itoh N, et al. Lethal effects of the anti‐Fas antibody in mice. Nature 1993 ; 364: 806–809. MEDLINE
21. 21 Yang Y, Mercep M, Ware CF, Ashwell JD. Fas and activation‐induced Fas ligand mediate apoptosis of T cell hybridomas: inhibition of Fas ligand expression by retinoic acid and glucocorticoids. J Exp Med 1995 ; 181: 1673–1682. MEDLINE
22. 22 Geley S, Hartmann BL, Kapelari K, Egle A, Villunger A, Heidacher D, Greil R, et al. The interleukin 1β‐converting enzyme inhibitor CrmA prevents Apo‐1/Fas‐ but not glucocorticoid‐induced poly (ADP‐ribose) polymerase cleavage and apoptosis in lymphoblastic leukemia cells. FEBS Lett 1997 ; 402: 36–40. MEDLINE
23. 23 Shi J, Fujieda H, Kokubo Y, Wake K. Apoptosis of neutrophils and their elimination by Kupffer cells in rat liver. Hepatology 1996 ; 24: 1256–1263. MEDLINE
24. 24 Takei Y, Kawano S, Nishimura Y, Goto M, Nagai H, Chen SS, Omae A, et al. Apoptosis: a new mechanism of endothelial and Kupffer cell killing. J Gastroenterol Hepatol 1995 ; 10: S65–S67. MEDLINE
25. 25 Meijer AJ, Gimpel JA, Deleeuw GA, Tager JM, Williamson JR. Role of anion translocation across the mitochondrial membrane in the regulation of urea synthesis from ammonia by isolated rat hepatocytes. J Biol Chem 1975 ; 250: 7728–7738. MEDLINE
26. 26 Zhang F, Warskulat U, Wettstein M, Schreiber R, Henninger HP, Decker K, Häussinger D. Hyperosmolarity stimulates prostaglandin synthesis and cyclooxygenase‐2 expression in activated rat liver macrophages. Biochem J 1995 ; 312: 135–143. MEDLINE
27. 27 Eyhorn S, Schlayer HJ, Henninger HP, Dieter P, Hermann R, Woort‐Menker M, Becker H, et al. Rat hepatic sinusoidal endothelial cells in monolayer culture. J Hepatol 1988 ; 6: 23–35. MEDLINE
28. 28 Dieter P, Schulze‐Specking A, Decker K. Differential inhibition of prostaglandin and superoxide production by dexamethasone in primary cultures of rat Kupffer cells. Eur J Biochem 1986 ; 159: 451–457. MEDLINE
29. 29 Pannetier C, Delassus S, Darche S, Saucier C, Kourilsky P. Quantitative titration of nucleic acids by enzymatic amplification reactions run to saturation. Nucleic Acids Res 1993 ; 21: 577–583. MEDLINE
30. 30 Delassus S, Couthino G, Saucier C, Darche S, Kourilsky P. Differential cytokine expression in maternal blood and placenta during murine gestation. J Immunol 1994 ; 152: 2411–2420. MEDLINE
31. 31 Enari M, Hug H, Nagata S. Involvement of an ICE‐like protease in Fas‐mediated apoptosis. Nature 1996 ; 375: 78–81.
32. 32 Gavrieli Y, Sherman Y, Ben‐Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992 ; 119: 493–501. MEDLINE
33. 33 Tanaka M, Suda T, Haze K, Nakamura N, Sato K, Kimura F, Motoyoshi K, et al. Fas ligand in human serum. Nat Med 1996 ; 3: 317–322.
34. 34 Carrera L, Gazzinelli RT, Badolato R, Hieny S, Müller W, Kühn R, Sacks D. Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow‐derived macrophages from susceptible and resistant mice. J Exp Med 1996 ; 183: 515–526. MEDLINE
35. 35 Cheng J, Zhou T, Liu C, Shapiro JP, Brauer MJ, Kiefer MC, Barr PJ, Mountz JD. Protection from Fas‐mediated apoptosis by a soluble form of the Fas molecule. Science 1994 ; 263: 1759–1762. MEDLINE
36. 36 Yano H, Fukuda K, Haramaki M, Momosaki S, Ogaswara S, Higaki K, Kojiro M. Expression of Fas and anti‐Fas‐mediated apoptosis in human hepatocellular carcinoma cell lines. J Hepatol 1996 ; 25: 454–464. MEDLINE
37. 37 Natoli G, Ianni A, Costanzo A, De Petrillo G, Ilari I, Chirillo P, Balsano C, Levrero. Resistance to Fas‐mediated apoptosis in human hepatoma cells. Oncogene 1995 ; 11: 1157–1164. MEDLINE
38. 38 Strand S, Hofmann WJ, Hug H, Müller M, Otto G, Strand D, Mariani SM, et al. Lymphocyte apoptosis induced by CD95 (APO‐1/Fas) ligand‐expressing tumor cells—a mechanism of immune evasion? Nat Med 1996 ; 12: 1361–1366.
39. 39 Falasca L, Bergamini A, Serafino A, Balabaud C, Dini L. Human Kupffer cell recognition and phagocytosis of apoptotic peripheral blood lymphocytes. Exp Cell Res 1996 ; 224: 152–162. MEDLINE